Free Trial

Bristol-Myers Squibb (BMY) Short Interest Ratio & Short Volume

Bristol-Myers Squibb logo
$57.70 -1.90 (-3.18%)
Closing price 03:59 PM Eastern
Extended Trading
$57.88 +0.17 (+0.29%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bristol-Myers Squibb Short Interest Data

Bristol-Myers Squibb (BMY) has a short interest of 37.01 million shares, representing 1.82% of the float (the number of shares available for trading by the public). This marks a 21.07% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.1, indicating that it would take 3.1 days of the average trading volume of 12.75 million shares to cover all short positions.

Current Short Interest
37,010,000 shares
Previous Short Interest
30,570,000 shares
Change Vs. Previous Month
+21.07%
Dollar Volume Sold Short
$2.18 billion
Short Interest Ratio
3.1 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
2,034,763,000 shares
Float Size
2,030,000,000 shares
Short Percent of Float
1.82%
Today's Trading Volume
13,233,852 shares
Average Trading Volume
12,747,984 shares
Today's Volume Vs. Average
104%
Short Selling Bristol-Myers Squibb?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Bristol-Myers Squibb and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BMY Short Interest Over Time

BMY Days to Cover Over Time

BMY Percentage of Float Shorted Over Time

Remove Ads

Bristol-Myers Squibb Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/202537,010,000 shares $2.18 billion +21.1%1.8%3.1 $59.01
2/28/202530,570,000 shares $1.83 billion +19.5%1.5%2.6 $59.71
2/15/202525,590,000 shares $1.38 billion -4.2%1.3%2.4 $53.85
1/31/202526,700,000 shares $1.57 billion -3.0%1.3%2.4 $58.86
1/15/202527,520,000 shares $1.54 billion +10.4%1.4%2.5 $55.96
12/31/202424,930,000 shares $1.41 billion -9.9%1.2%2.4 $56.56
12/15/202427,660,000 shares $1.54 billion +8.1%1.4%2.4 $55.78
11/30/202425,600,000 shares $1.52 billion -0.7%1.3%2.3 $59.22
11/15/202425,770,000 shares $1.45 billion +10.0%1.3%2.3 $56.22
10/31/202423,420,000 shares $1.31 billion +4.1%1.2%2.1 $55.74
10/15/202422,500,000 shares $1.19 billion +12.3%1.1%1.9 $52.76
9/30/202420,030,000 shares $1.04 billion -8.1%1.0%1.5 $51.74
9/15/202421,790,000 shares $1.07 billion -2.1%1.1%1.6 $49.13
8/31/202422,260,000 shares $1.11 billion -20.5%1.1%1.5 $49.95
8/15/202428,010,000 shares $1.38 billion +6.0%1.4%1.8 $49.12
7/31/202426,420,000 shares $1.26 billion -17.6%1.3%1.6 $47.56
7/15/202432,060,000 shares $1.29 billion +1.4%1.6%2 $40.15
6/30/202431,620,000 shares $1.31 billion +4.4%1.6%2.1 $41.53
6/15/202430,290,000 shares $1.25 billion +5.4%1.5%2.1 $41.20
5/31/202428,730,000 shares $1.18 billion +1.6%1.4%1.8 $41.13
5/15/202428,270,000 shares $1.26 billion +0.9%1.4%1.8 $44.55
4/30/202428,020,000 shares $1.23 billion -18.5%1.4%1.8 $43.96
4/15/202434,360,000 shares $1.67 billion -2.2%1.7%2.2 $48.51
3/31/202435,120,000 shares $1.90 billion -5.7%1.7%2.2 $54.23
3/15/202437,250,000 shares $1.96 billion +14.1%1.8%2.2 $52.49
2/29/202432,650,000 shares $1.66 billion +3.7%1.6%2.1 $50.73
2/15/202431,490,000 shares $1.56 billion +1.3%1.6%2.1 $49.45
1/31/202431,090,000 shares $1.52 billion +6.5%1.5%2 $48.87
1/15/202429,190,000 shares $1.47 billion +30.8%1.4%1.9 $50.31
12/31/202322,310,000 shares $1.14 billion -7.4%1.1%1.5 $51.31
12/15/202324,100,000 shares $1.23 billion -11.3%1.2%1.7 $50.84
11/30/202327,170,000 shares $1.34 billion +1.4%1.3%2 $49.38
11/15/202326,800,000 shares $1.38 billion +14.5%1.3%2.1 $51.60
10/31/202323,400,000 shares $1.21 billion -12.5%1.2%1.9 $51.53
10/15/202326,750,000 shares $1.51 billion -15.3%1.3%2.4 $56.47
9/30/202331,590,000 shares $1.83 billion -14.6%1.5%2.9 $58.04
9/15/202336,980,000 shares $2.18 billion -15.5%1.8%3.5 $59.00
8/31/202343,760,000 shares $2.70 billion -18.2%2.1%4.4 $61.65
8/15/202353,510,000 shares $3.30 billion +221.6%2.6%5.6 $61.75
7/31/202316,640,000 shares $1.04 billion -8.6%0.8%1.9 $62.20
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

7/15/202318,210,000 shares $1.13 billion +1.2%0.9%2.2 $61.94
6/30/202318,000,000 shares $1.15 billion -1.9%0.9%2.2 $63.94
6/15/202318,340,000 shares $1.19 billion -2.7%0.9%2.3 $64.68
5/31/202318,840,000 shares $1.21 billion -12.3%0.9%2.3 $64.44
5/15/202321,490,000 shares $1.46 billion +13.6%1.0%2.7 $68.17
4/30/202318,920,000 shares $1.26 billion +5.8%0.9%2.4 $66.77
4/15/202317,880,000 shares $1.26 billion +3.5%0.9%2.3 $70.45
3/31/202317,270,000 shares $1.20 billion -17.0%0.8%2.1 $69.31
3/15/202320,810,000 shares $1.40 billion +22.3%1.0%2.5 $67.48
2/28/202317,020,000 shares $1.17 billion -4.0%0.8%2.1 $68.96
2/15/202317,720,000 shares $1.27 billion -14.5%0.9%2.1 $71.47
1/31/202320,720,000 shares $1.51 billion -1.2%1.0%2.3 $72.65
1/15/202320,960,000 shares $1.52 billion +14.9%1.0%2.3 $72.51
12/30/202218,250,000 shares $1.31 billion -26.7%0.9%2 $71.95
12/15/202224,880,000 shares $1.87 billion -1.4%1.2%2.6 $75.00
11/30/202225,220,000 shares $2.02 billion +3.5%1.2%2.6 $80.28
11/15/202224,360,000 shares $1.86 billion -1.7%1.2%2.5 $76.28
10/31/202224,770,000 shares $1.92 billion +7.3%1.2%2.6 $77.47
10/15/202223,080,000 shares $1.63 billion -4.6%1.1%2.5 $70.62
9/30/202224,180,000 shares $1.72 billion +4.7%1.1%2.5 $71.09
9/15/202223,090,000 shares $1.66 billion +1.7%1.1%2.4 $71.78
8/31/202222,710,000 shares $1.53 billion -4.7%1.1%2.2 $67.41
8/15/202223,840,000 shares $1.78 billion -14.3%1.1%2.2 $74.53
7/31/202227,830,000 shares $2.05 billion +1.8%1.3%2.3 $73.78
7/15/202227,330,000 shares $2.07 billion -29.9%1.3%2 $75.65
6/30/202238,980,000 shares $3.00 billion +13.1%1.8%2.7 $77.00
6/15/202234,460,000 shares $2.52 billion +4.3%1.6%2.3 $73.02
5/31/202233,040,000 shares $2.49 billion +2.7%1.6%2.2 $75.45
5/15/202232,180,000 shares $2.44 billion -9.0%1.5%2.1 $75.80
4/30/202235,370,000 shares $2.66 billion -16.3%1.7%2.2 $75.27
4/15/202242,240,000 shares $3.27 billion -10.8%2.0%2.8 $77.51
3/31/202247,340,000 shares $3.46 billion -11.9%2.2%3.1 $73.03
3/15/202253,730,000 shares $3.75 billion -15.0%2.4%3.8 $69.75
2/28/202263,200,000 shares $4.34 billion -10.8%2.9%4.5 $68.67
2/15/202270,880,000 shares $4.80 billion +171.4%3.2%4.9 $67.77
1/31/202226,120,000 shares $1.69 billion +10.2%1.2%1.9 $64.89
1/15/202223,710,000 shares $1.54 billion +16.6%1.1%1.8 $64.93
12/31/202120,340,000 shares $1.27 billion -7.3%0.9%1.6 $62.35
12/15/202121,930,000 shares $1.33 billion -5.7%1.0%1.7 $60.61
11/30/202123,260,000 shares $1.25 billion +14.8%1.1%1.9 $53.63
11/15/202120,260,000 shares $1.21 billion -9.6%0.9%1.8 $59.62
10/29/202122,400,000 shares $1.31 billion +7.5%1.0%2.2 $58.40
10/15/202120,830,000 shares $1.22 billion +4.6%0.9%2.2 $58.36
9/30/202119,910,000 shares $1.18 billion -5.2%0.9%2.2 $59.17
9/15/202120,990,000 shares $1.30 billion +3.3%1.0%2.4 $62.00
8/31/202120,320,000 shares $1.36 billion +5.1%0.9%2.4 $66.86
8/13/202119,340,000 shares $1.31 billion -11.7%0.9%2.2 $67.51
7/30/202121,910,000 shares $1.49 billion +13.1%1.0%2.4 $67.87
7/15/202119,380,000 shares $1.31 billion +19.8%N/A2 $67.43
6/30/202116,180,000 shares $1.08 billion -22.2%N/A1.6 $66.82
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

6/15/202120,790,000 shares $1.40 billion +24.0%N/A2 $67.42
5/28/202116,770,000 shares $1.10 billion +4.9%N/A1.6 $65.72
5/14/202115,990,000 shares $1.04 billion -23.8%N/A1.4 $65.04
4/30/202120,970,000 shares $1.32 billion +10.5%N/A1.7 $62.89
4/15/202118,980,000 shares $1.21 billion +12.6%N/A1.5 $63.81
3/31/202116,860,000 shares $1.07 billion -33.0%N/A1.3 $63.31
3/15/202125,160,000 shares $1.53 billion -10.8%N/A2 $60.64
2/26/202128,190,000 shares $1.75 billion +35.6%N/A2.3 $62.10
2/12/202120,790,000 shares $1.25 billion +6.8%N/A1.8 $59.99
1/29/202119,470,000 shares $1.21 billion -1.3%N/A1.7 $62.29
1/15/202119,730,000 shares $1.30 billion +31.4%N/A1.8 $66.02
12/31/202015,020,000 shares $930.04 million -2.5%N/A1.4 $61.92
12/15/202015,410,000 shares $924.14 million +0.7%N/A1.5 $59.97
11/30/202015,300,000 shares $964.67 million -5.2%N/A1.5 $63.05
11/15/202016,140,000 shares $1.03 billion +2.7%N/A1.5 $63.62
10/30/202015,710,000 shares $909.92 million +14.3%N/A1.5 $57.92
10/15/202013,750,000 shares $1.49 billion +18.3%N/A1.4 $108.24
9/30/202011,620,000 shares $1.26 billion -19.1%N/A1.2 $108.24
9/15/202014,360,000 shares $1.55 billion -3.4%N/A1.4 $108.24
8/31/202014,860,000 shares $1.61 billion +2.8%N/A1.3 $108.24
8/14/202014,450,000 shares $1.56 billion -30.2%N/A1.1 $108.24
7/31/202020,700,000 shares $2.24 billion -9.6%N/A1.5 $108.24
7/15/202022,890,000 shares $2.48 billion +5.8%N/A1.6 $108.24
6/30/202021,640,000 shares $2.34 billion -29.3%1.3%1.4 $108.24
6/15/202030,590,000 shares $1.69 billion -18.0%N/A1.8 $55.10
5/29/202037,320,000 shares $4.04 billion +8.4%N/A2.2 $108.24
5/15/202034,430,000 shares $3.73 billion +8.0%N/A2 $108.24
4/30/202031,870,000 shares $3.45 billion -3.6%N/A2 $108.24
4/15/202033,050,000 shares $3.58 billion +20.4%N/A2 $108.24

BMY Short Interest - Frequently Asked Questions

What is Bristol-Myers Squibb's current short interest?

Short interest is the volume of Bristol-Myers Squibb shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 37,010,000 shares of BMY short. 1.82% of Bristol-Myers Squibb's shares are currently sold short. Learn More on Bristol-Myers Squibb's current short interest.

What is a good short interest ratio for Bristol-Myers Squibb?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BMY shares currently have a short interest ratio of 3.0. Learn More on Bristol-Myers Squibb's short interest ratio.

Which institutional investors are shorting Bristol-Myers Squibb?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bristol-Myers Squibb: Total Wealth Planning & Management Inc., Wolverine Trading LLC, Squarepoint Ops LLC, Nomura Holdings Inc., Maven Securities LTD, Millennium Management LLC, Moore Capital Management LP, Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Cetera Investment Advisers, Cantor Fitzgerald L. P., Citadel Advisors LLC, Capstone Investment Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Lido Advisors LLC, Tudor Investment Corp ET AL, CMT Capital Markets Trading GmbH, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, HAP Trading LLC, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Wells Fargo & Company MN, JPMorgan Chase & Co., LPL Financial LLC, Simplex Trading LLC, Delta Accumulation LLC, Fulcrum Asset Management LLP, Allianz Asset Management GmbH, Wolverine Asset Management LLC, Genus Capital Management Inc., IMC Chicago LLC, and CenterStar Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Bristol-Myers Squibb?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.82% of Bristol-Myers Squibb's floating shares are currently sold short.

Is Bristol-Myers Squibb's short interest increasing or decreasing?

Bristol-Myers Squibb saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 37,010,000 shares, an increase of 21.1% from the previous total of 30,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Bristol-Myers Squibb's float size?

Bristol-Myers Squibb currently has issued a total of 2,034,763,000 shares. Some of Bristol-Myers Squibb's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bristol-Myers Squibb currently has a public float of 2,030,000,000 shares.

How does Bristol-Myers Squibb's short interest compare to its competitors?

1.82% of Bristol-Myers Squibb's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bristol-Myers Squibb: Johnson & Johnson (1.03%), AbbVie Inc. (1.12%), Merck & Co., Inc. (1.47%), Pfizer Inc. (1.75%), Zoetis Inc. (1.59%), Royalty Pharma plc (4.66%), Corcept Therapeutics Incorporated (17.53%), Jazz Pharmaceuticals plc (7.80%), Perrigo Company plc (2.80%), Supernus Pharmaceuticals, Inc. (10.04%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Bristol-Myers Squibb stock?

Short selling BMY is an investing strategy that aims to generate trading profit from Bristol-Myers Squibb as its price is falling. BMY shares are trading down $1.90 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bristol-Myers Squibb?

A short squeeze for Bristol-Myers Squibb occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BMY, which in turn drives the price of the stock up even further.

How often is Bristol-Myers Squibb's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BMY, twice per month. The most recent reporting period available is March, 15 2025.




This page (NYSE:BMY) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners